{
"papers": [
{
"n": 15,
"doi": "10.1186/s43556-025-00373-5",
"value": "2014 Pa",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Ma2025c",
"text_access": "fulltext",
"study_system": "rat",
"value_source_sentence": "pmc Mol Biomed Mol Biomed 4128 molbio Molecular Biomedicine 2662-8651 Springer PMC12675902 PMC12675902.1 12675902 12675902 41335282 10.1186/s43556-025-00373-5 373 1 Review Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applications "
},
{
"n": 6,
"doi": "10.1038/s41398-024-03055-y",
"value": "10 mg/kg",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Inserra2024",
"text_access": "fulltext",
"study_system": "rat",
"value_source_sentence": "Psilocybin at the dose of 10 mg/kg increases oxidative DNA damage in the PFC and hippocampus Higher-than clinically-relevant doses of"
},
{
"n": 37,
"doi": "10.3389/fnmol.2025.1716792",
"value": "p = 0.0002",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Cherif2026",
"text_access": "fulltext",
"study_system": "mouse",
"value_source_sentence": "0001; post hoc Tukey: p = 0.0002 at 4 h, p < 0."
},
{
"n": 6,
"doi": "10.3390/cancers18061001",
"value": "53 pa",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Kubiak2026",
"text_access": "fulltext",
"study_system": "rat",
"value_source_sentence": "The miR-34a mimic MRX34 (liposomal formulation) entered Phase I trials for advanced solid tumors (including limited PDAC cases), showing manageable toxicity and some activity via p53 pathway restoration, though development halted due to immune-related adverse events."
},
{
"n": null,
"doi": "10.3389/fimmu.2025.1637626",
"value": "50%",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Wang2025c",
"text_access": "fulltext",
"study_system": "rat",
"value_source_sentence": "</i>, GD2 monoclonal antibodies) into international clinical guidelines, the 5-year survival rate of patients with NB persistently remains lower than 50%."
},
{
"n": null,
"doi": "10.3389/fcimb.2025.1617198",
"value": "20%",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Bautista2025",
"text_access": "fulltext",
"study_system": "rat",
"value_source_sentence": "Viruses contribute to approximately 15-20% of global cancer cases, yet the full spectrum of their oncogenic mechanisms continues to be uncovered."
},
{
"n": 2721,
"doi": "10.7759/cureus.94508",
"value": "2721 pa",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Idahor2025",
"text_access": "fulltext",
"study_system": "rat",
"value_source_sentence": "An earlier research was conducted on 2721 participants with chronic pain on prescription opioid pain medication, to evaluate the effects of certain genes on pain perception."
},
{
"n": null,
"doi": "10.1093/eep/dvaf025",
"value": "19 pa",
"metric": "Histone modification fold-change or gene expression change",
"cite_key": "Gemmati2025",
"text_access": "fulltext",
"study_system": "rat",
"value_source_sentence": "A common characteristic shared worldwide is that the rates of IPV increased during the COVID-19 pandemic because of the lockdown [ 142 ]."
}
],
"n_definition": "Animals per group or biological replicates",
"scope_region": "Multiple brain regions (NAc, PFC, VTA)",
"comparison_id": "fig_sec3_epigenetic_drug_comparison",
"comparison_type": "cross-study",
"scope_population": "Bulk tissue or sorted cell populations",
"homogeneity_check": {
"caveats": [
"Different histone marks measured (H3K9ac, H3K27me3, H3K4me3)",
"Different genomic loci and gene promoters",
"Different drugs (cocaine, alcohol, methamphetamine)",
"Different brain regions (NAc, PFC, VTA)",
"Highly heterogeneous - heatmap groups by mark type rather than direct comparison"
],
"comparable": false
},
"suggested_plot_type": "heatmap"
}